HESHAM MOHAMED to Myelodysplastic Syndromes
This is a "connection" page, showing publications HESHAM MOHAMED has written about Myelodysplastic Syndromes.
Connection Strength
0.189
-
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial. Lancet Haematol. 2023 Jan; 10(1):e46-e58.
Score: 0.189